Vault-13

ADVERUM BIOTECHNOLOGIES INC

COM · CUSIP 00773U108

2 institutional holders -1 vs Q1 2024
2,515,1612.5m shares reported held*
$17.3mreported value*
0 new 0 added 1 reduced 1 sold out net sold ≈ $7.3m (-1.1m shares)

* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Implied quarter-end price ≈ $6.86.

Trends to Q2 2024

Institutional holders

Managers reporting a position, each quarter

050100Q3 22: 79Q4 22: 60Q1 23: 56Q2 23: 59Q3 23: 62Q4 23: 62Q1 24: 3Q2 24: 22Q3 22Q1 23Q3 23Q1 24Q2 24
Numbers
QuarterHolders
Q3 202279
Q4 202260
Q1 202356
Q2 202359
Q3 202362
Q4 202362
Q1 20243
Q2 20242

Buyers vs sellers

Managers adding to or starting a position, vs cutting or selling out

Bought or addedCut or sold out
1000100Q4 22: 19 bought or addedQ4 22: 47 cut or sold outQ4 22Q1 23: 20 bought or addedQ1 23: 26 cut or sold outQ2 23: 20 bought or addedQ2 23: 29 cut or sold outQ2 23Q3 23: 25 bought or addedQ3 23: 28 cut or sold outQ4 23: 25 bought or addedQ4 23: 25 cut or sold outQ4 23Q1 24: 2 bought or addedQ1 24: 62 cut or sold outQ2 24: 0 bought or addedQ2 24: 2 cut or sold outQ2 24
Numbers
QuarterBought or addedCut or sold out
Q4 20221947
Q1 20232026
Q2 20232029
Q3 20232528
Q4 20232525
Q1 2024262
Q2 202402

Calls vs puts

Options held, notional value, last 4 quarters. P/C = puts ÷ calls

CallsPuts
$0$200k$400k$600kQ3 23 calls: $419.7kQ3 23 puts: $300Q3 23P/C 0.00Q4 23 calls: $42.4kQ4 23 puts: $3.0kQ4 23P/C 0.07Q1 24 calls: $0Q1 24 puts: $0Q1 24P/C —Q2 24 calls: $0Q2 24 puts: $0Q2 24P/C —
Numbers
QuarterCallsPutsP/C
Q3 2023$419.7k$3000.00
Q4 2023$42.4k$3.0k0.07
Q1 2024$0$0—
Q2 2024$0$0—

Biggest buyers

None

Biggest sellers

Frazier Life Sciences Management, L.P. Sold out -1,069,244-1.1m
Versant Venture Management, LLC Reduced -1-1

Major shareholders (over 5%)

Anyone who owns more than 5% of a class of the company's shares has to say so: on Schedule 13D if they may try to influence or control the company, on 13G if they're a passive investor, and update it as the stake changes. Each holder's latest filing, from 19 Dec 2024 on; percentages are of the share class, as the holder worked them out.

HolderStakeChangeShares Last filed
TCG Crossover GP II, LLC 13G · passive investor filed 2025-05-15 8.9% 1.9m 2025-05-15

Fell to 5% or below in the last year: BML Investment Partners, L.P. (0.0%, 2025-12-09)

Holders, Q2 2024

#ManagerLocationShares Value% of their portfolioChangeShares change
1 TCG Crossover Management, LLC 1.44% of their portfolio PALO ALTO, CA 2,008,3402.0m $13.8m $13.8m 1.44% Unchanged
2 Versant Venture Management, LLC 4.50% of their portfolio San Francisco, CA 506,821506.8k $3.5m $3.5m 4.50% Reduced -1 -1